|
Re: Quick question
This is what the National Cancer Institute at the NIH is reporting. They do make it sound like the trial is finishing. But this isn't the first time I've heard of NIH doing some premature reporting. I remember reading about Peptide T and that it actually reduced viral loads in AIDs patients, but NIH didn't wait for those results and published a report that squelched the funding.
In the body of the article it does mention that the follow up data was just a little over 5 years, so perhaps they think we recognize it is an interim report.
Becky, since your are familiar with the trial, I hope you will let us know when the final data is available.
Thanks!
__________________
Diagnosed 2007
Stage IIb Invasive Ductal Carcinoma, Pagets, 3 of 15 positive nodes
Traditional Treatment: Mastectomy and Axillary Node Dissection followed by Taxotere, 6 treatments and 1 year of Herceptin, no radiation
Former Chemo Ninja "Takizi Zukuchiri"
Additional treatments:
GP2 vaccine, San Antonio Med Ctr
Prescriptive Exercise for Cancer Patients
ENERGY Study, UCSD La Jolla
Reconstruction: TRAM flap, partial loss, Revision
The content of my posts are meant for informational purposes only. The medical information is intended for general information only and should not be used in any way to diagnose, treat, cure, or prevent disease
Last edited by 'lizbeth; 07-24-2013 at 07:38 AM..
Reason: addition
|